233 related articles for article (PubMed ID: 35831234)
21. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
22. Steroid hormone levels in postmenopausal hysterectomised women with and without ovarian conservation: the continuous endocrine function of the ovaries.
Nunes E; Gallardo E; Morgado-Nunes S; Fonseca-Moutinho J
J Obstet Gynaecol; 2023 Dec; 43(1):2141618. PubMed ID: 36331514
[TBL] [Abstract][Full Text] [Related]
23. Headache prevalence in transgender and gender diverse youth: A single-center case-control study.
Hranilovich JA; Millington K
Headache; 2023 Apr; 63(4):517-522. PubMed ID: 36988085
[TBL] [Abstract][Full Text] [Related]
24. Outcomes Following Gender Affirming Phalloplasty: A Systematic Review and Meta-Analysis.
Wang AMQ; Tsang V; Mankowski P; Demsey D; Kavanagh A; Genoway K
Sex Med Rev; 2022 Oct; 10(4):499-512. PubMed ID: 36031521
[TBL] [Abstract][Full Text] [Related]
25. Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women.
Orozco LJ; Tristan M; Vreugdenhil MM; Salazar A
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD005638. PubMed ID: 25101365
[TBL] [Abstract][Full Text] [Related]
26. Gender-affirming hormones and surgery in transgender children and adolescents.
Mahfouda S; Moore JK; Siafarikas A; Hewitt T; Ganti U; Lin A; Zepf FD
Lancet Diabetes Endocrinol; 2019 Jun; 7(6):484-498. PubMed ID: 30528161
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of pelvic pain in transgender individuals on testosterone.
Grimstad FW; Boskey ER; Clark RS; Ferrando CA
J Sex Med; 2023 Nov; 20(12):1459-1465. PubMed ID: 37837637
[TBL] [Abstract][Full Text] [Related]
28. Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women.
Orozco LJ; Salazar A; Clarke J; Tristan M
Cochrane Database Syst Rev; 2008 Jul; (3):CD005638. PubMed ID: 18646133
[TBL] [Abstract][Full Text] [Related]
29. Fertility preservation for transgender adolescents and young adults: a systematic review.
Baram S; Myers SA; Yee S; Librach CL
Hum Reprod Update; 2019 Nov; 25(6):694-716. PubMed ID: 31633751
[TBL] [Abstract][Full Text] [Related]
30. Endocrinological and ovarian histological investigations in assigned female at birth transgender people undergoing testosterone therapy.
Borrás A; Manau MD; Fabregues F; Casals G; Saco A; Halperin I; Mora M; Goday A; Barral Y; Carmona F
Reprod Biomed Online; 2021 Aug; 43(2):289-297. PubMed ID: 34244072
[TBL] [Abstract][Full Text] [Related]
31. Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.
Pirtea P; Ayoubi JM; Desmedt S; T'Sjoen G
Fertil Steril; 2021 Oct; 116(4):936-942. PubMed ID: 34481638
[TBL] [Abstract][Full Text] [Related]
32. Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series.
Grimstad FW; Fowler KG; New EP; Ferrando CA; Pollard RR; Chapman G; Gomez-Lobo V; Gray M
Am J Obstet Gynecol; 2019 Mar; 220(3):257.e1-257.e7. PubMed ID: 30579875
[TBL] [Abstract][Full Text] [Related]
33. Incidence, Contributing Factors, and Implications for Clinical Management of Polycythemia in Transmasculine Patients on Testosterone.
Tatarian J; Walcott Q; Richardson K
LGBT Health; 2023 Jan; 10(1):72-79. PubMed ID: 35920834
[No Abstract] [Full Text] [Related]
34. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
Salvador S; Scott S; Francis JA; Agrawal A; Giede C
J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
[TBL] [Abstract][Full Text] [Related]
35. Management of testosterone around ovarian stimulation in transmasculine patients: challenging common practices to meet patient needs-2 case reports.
Moravek MB; Dixon M; Pena SM; Obedin-Maliver J
Hum Reprod; 2023 Mar; 38(3):482-488. PubMed ID: 36644915
[TBL] [Abstract][Full Text] [Related]
36. Preservation of Fertility in Transgender Men on Long-Term Testosterone Therapy: A Systematic Review of Oocyte Retrieval Outcomes During and After Exogenous Androgen Exposure.
Barrero JA; Mockus I
Transgend Health; 2023 Oct; 8(5):408-419. PubMed ID: 37810944
[TBL] [Abstract][Full Text] [Related]
37. Impaired in vitro fertilization outcomes following testosterone treatment improve with washout in a mouse model of gender-affirming hormone treatment.
Schwartz AR; Xu M; Henderson NC; Dela Cruz C; Pfau D; Padmanabhan V; Shikanov A; Moravek MB
Am J Obstet Gynecol; 2023 Oct; 229(4):419.e1-419.e10. PubMed ID: 37453652
[TBL] [Abstract][Full Text] [Related]
38. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
McFarlane T; Zajac JD; Cheung AS
Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
[TBL] [Abstract][Full Text] [Related]
39. Hysterectomy controversies: ovarian and cervical preservation.
Jacoby VL
Clin Obstet Gynecol; 2014 Mar; 57(1):95-105. PubMed ID: 24488053
[TBL] [Abstract][Full Text] [Related]
40. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.
Caanen MR; Schouten NE; Kuijper EAM; van Rijswijk J; van den Berg MH; van Dulmen-den Broeder E; Overbeek A; van Leeuwen FE; van Trotsenburg M; Lambalk CB
Hum Reprod; 2017 Jul; 32(7):1457-1464. PubMed ID: 28505246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
